Leveraging patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, a novel approach to site and patient access, and comprehensive lab services via PPD® Laboratories. We serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships, functional service partnerships and PPD® Biotech, for biotech and small to midsize pharma companies.
In an increasingly complex research landscape, biopharmaceutical leaders can depend on PPD for quality performance, continual innovation and trusted partnership.
PPD: Dedicated to helping deliver life-changing therapies
Jun 25, 2020
May 21, 2020
PPD Common Stock
Data Provided by Refinitiv. Minimum 15 minutes delayed.